Clinical Trials Directory

Trials / Completed

CompletedNCT00870597

Transconjunctival Sutureless 25-Gauge Vitrectomy

Transconjunctival Sutureless 25-Gauge Vitrectomy for Visually Significant Vitreous Floaters in Patients With Multifocal Intraocular Lens

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Hospital Oftalmologico de Brasilia · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation.

Detailed description

Purpose: The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation. Setting: Hospital Oftalmológico de Brasília, Brasília, DF, Brazil. Methods: Fourteen eyes of 11 patients with multifocal IOL implant associated with vitreous opacities that underwent 25-gauge vitrectomy were prospectively analyzed. Information collected included near and distance uncorrected visual acuity (UCDVA), best corrected distance visual acuity (BCDVA), and the spherical equivalent (SE) before and 3 months after vitrectomy. Patients were questioned about surgery satisfaction and visual improvement after vitrectomy.

Conditions

Interventions

TypeNameDescription
PROCEDUREMultifocal IOL implantation + Vitrectomy25-gauge transconjuntival sutureless vitrectomy (TSV)
PROCEDUREMultifocal IOL implantation - VitrectomyMultifocal IOL implantation without transconjunctival vitrectomy

Timeline

Start date
2007-01-01
Primary completion
2008-02-01
Completion
2008-12-01
First posted
2009-03-27
Last updated
2009-03-27

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00870597. Inclusion in this directory is not an endorsement.